E31V (p.Glu31Val) variant of MAP2K1 (Q02750)
E31V (p.Glu31Val) in MAP2K1 (Q02750) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The record also includes variant effect predictions, experimental measurements, and structural context.
E31V (p.Glu31Val) variant details
- p.Glu31Val
- NCI-TCGA TCGA novel
- Ensembl rs2140578404
- Variant assessed as somatic; moderate impact.
- Missense
- MetaLR 0.79
- MetaSVM 0.57
- SIFT 0.36
- UniProt: Variant assessed as somatic; moderate impact.
- Structural context available
- Dabrafenib and Cetuximab HT-29 cells, base editing z-scores (predicted consequen: score 1.02